(Q36075474)

12 August 2017

1 reference

title

Immunological and anti-chaperone therapeutic approaches for Alzheimer disease (English)

1 reference

12 August 2017

0 references

0 references

Thomas Wisniewski

1

1 reference

12 August 2017

Blas Frangione

series ordinal

2

1 reference

12 August 2017

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

15

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

72-77

1 reference

APOE genotype influences acquisition and recall following traumatic brain injury

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00102.X

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00102.X

Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00102.X

Setback for an Alzheimer's disease vaccine: lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00102.X

Neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00102.X

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00102.X

A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00102.X

Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00102.X

Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2005.TB00102.X

10.1111/J.1750-3639.2005.TB00102.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference